Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00027937
What this trial is testing

Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)UnknownNCT05097443
What this trial is testing

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Who this might be right for
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsHigh Grade B-Cell Lymphoma, Not Otherwise SpecifiedDiffuse Large B-cell Lymphoma+2 more
Shandong Provincial Hospital 130
Early research (Phase 1)Ended earlyNCT04844086
What this trial is testing

RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma Refractory+5 more
Eden BioCell Ltd. 2
Testing effectiveness (Phase 2)Study completedNCT01182415
What this trial is testing

High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaCNS Lymphoma
Massachusetts General Hospital 30
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03749018
What this trial is testing

Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaAnn Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell LymphomaAnn Arbor Stage II B-Cell Non-Hodgkin Lymphoma+11 more
David Bond, MD 30
Large-scale testing (Phase 3)Study completedNCT00039910
What this trial is testing

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Who this might be right for
Non-Hodgkin LymphomaHodgkin DiseaseThrombocytopenia
Pfizer 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT04542824
What this trial is testing

Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaPrimary Mediastinal Large B Cell Lymphoma+3 more
Genmab 78
Not applicableActive Not RecruitingNCT00039676
What this trial is testing

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Who this might be right for
Waldenstrom MacroglobulinemiaChronic Lymphocytic LeukemiaHodgkin Disease+2 more
National Cancer Institute (NCI) 1,836
Early research (Phase 1)WithdrawnNCT00521261
What this trial is testing

Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT05050630
What this trial is testing

Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL

Who this might be right for
Age Range ≥16 Years, Gender UnlimitedHistopathology Confirmed Diffuse Large B-cell Lymphoma or High-grade B-cell LymphomaReceived Prior First-line Chemotherapy for DLBCL or HGBL, Failed to Reach CR for Four Cycles, or Relapsed+4 more
Affiliated Hospital to Academy of Military Medical Sciences
Early research (Phase 1)Ended earlyNCT01045928
What this trial is testing

Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Adult Non-Hodgkin LymphomaAdult Grade III Lymphomatoid GranulomatosisContiguous Stage II Adult Burkitt Lymphoma+77 more
Case Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Ended earlyNCT00141700
What this trial is testing

Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin's
University of Michigan Rogel Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT00398411
What this trial is testing

Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells

Who this might be right for
Hodgkin DiseaseNon-Hodgkin LymphomaMultiple Myeloma+1 more
University of Cologne 66
Testing effectiveness (Phase 2)Study completedNCT00002521
What this trial is testing

Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Temple University
Testing effectiveness (Phase 2)Active Not RecruitingNCT05202782
What this trial is testing

Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma Associated With Chronic InflammationEBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell Lymphoma, Not Otherwise Specified+16 more
Northwestern University
Testing effectiveness (Phase 2)WithdrawnNCT03579927
What this trial is testing

CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma

Who this might be right for
CD19 PositiveMantle Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma+4 more
M.D. Anderson Cancer Center
Early research (Phase 1)WithdrawnNCT05134740
What this trial is testing

(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL).

Who this might be right for
Hodgkins LymphomaNon Hodgkins Lymphoma
Baylor College of Medicine
Large-scale testing (Phase 3)UnknownNCT00003815
What this trial is testing

Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Scotland and Newcastle Lymphoma Group
Testing effectiveness (Phase 2)WithdrawnNCT01163201
What this trial is testing

T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+14 more
Masonic Cancer Center, University of Minnesota
Next Page
73
24